# US 2022/0011303 A1 · Immunochromatography

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0011303 A1
- Document ID: US20220011303A1
- Status: Published application
- Kind: A1
- Application number: 17/487,534
- Filed: 2021-09-28
- Published: 2022-01-13
- Earliest claimed: 2019-03-29
- Assignees: FUJIFILM Corporation
- Applicants: FUJIFILM Corporation
- Inventors: Yoshihiro ABURAYA; Naoyuki NISHIKAWA; Junichi KATADA; Dai UJIHARA; Atsuhiko WADA
- Web page: https://patentgrep.com/patent/US20220011303A1

## CPC

- G01N 33/54326: {Magnetic particles}
- G01N 33/54388: {based on lateral flow}
- G01N 33/54346: {Nanoparticles}
- H01F 1/0054: {Coated nanoparticles, e.g. nanoparticles coated with organic surfactant}
- B82Y 25/00: Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- B82Y 40/00: Manufacture or treatment of nanostructures
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01F: MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

An object of the present invention is to provide immunochromatography exhibiting excellent magnetic detection sensitivity. The immunochromatography of the present invention is immunochromatography including a mixing step of mixing a specimen that is capable of containing a test substance with a modified composite particle that is a composite particle modified with a first binding substance that is capable of binding to the test substance, to obtain a complex of the test substance in the specimen and the modified composite particle; a developing step of developing the complex on an insoluble carrier having a reaction site at which a second binding substance capable of binding to the test substance is immobilized; a capturing step of capturing the complex at the reaction site of the insoluble carrier; and a silver amplification step of silver-amplifying the complex captured in the capturing step, where the composite particle is a composite particle of a magnetic particle and a gold particle carried on a surface of the magnetic particle.

## Claims

### Claim 1

Immunochromatography comprising:
a mixing step of mixing a specimen that is capable of containing a test substance with a modified composite particle that is a composite particle modified with a first binding substance that is capable of binding to the test substance, to obtain a complex of the test substance in the specimen and the modified composite particle;
a developing step of developing the complex on an insoluble carrier having a reaction site at which a second binding substance capable of binding to the test substance is immobilized;
a capturing step of capturing the complex at the reaction site of the insoluble carrier; and
a silver amplification step of silver-amplifying the complex captured in the capturing step,
wherein the composite particle is a composite particle of a magnetic particle and a gold particle carried on a surface of the magnetic particle.

### Claim 2 (depends on 1)

The immunochromatography according to claim 1,
wherein a material of the magnetic particle is iron oxide.

### Claim 3 (depends on 1)

The immunochromatography according to claim 1, further comprising a collection step of collecting the modified composite particle or the complex using magnetism, before the developing step.

### Claim 4 (depends on 1)

The immunochromatography according to claim 1,
wherein the number of carried gold particles of the composite particle is 1 or more and 300 or less.

### Claim 5 (depends on 1)

The immunochromatography according to claim 1,
wherein in the composite particle, an average particle diameter of the gold particles is smaller than an average particle diameter of the magnetic particles.

### Claim 6 (depends on 1)

The immunochromatography according to claim 1,
wherein an average particle diameter of the composite particles is 10 nm to 300 nm.

### Claim 7 (depends on 1)

The immunochromatography according to claim 1,
wherein the silver amplification step is a step of silver-amplifying the complex captured in the capturing step, using a reducing agent solution and a silver amplification solution.

### Claim 8 (depends on 7)

The immunochromatography according to claim 7,
wherein an angle between a developing direction of the reducing agent solution in the silver amplification step and a developing direction of the complex in the developing step is 0 degrees to 150 degrees.

### Claim 9 (depends on 7)

The immunochromatography according to claim 7,
wherein an angle between a developing direction of the silver amplification solution in the silver amplification step and a developing direction of the complex in the developing step is 45 degrees to 180 degrees.

### Claim 10 (depends on 1)

The immunochromatography according to claim 1,
wherein both optical detection and magnetic detection are possible.

### Claim 11 (depends on 2)

The immunochromatography according to claim 2 further comprising a collection step of collecting the modified composite particle or the complex using magnetism, before the developing step.

### Claim 12 (depends on 2)

The immunochromatography according to claim 2,
wherein the number of carried gold particles of the composite particle is 1 or more and 300 or less.

### Claim 13 (depends on 2)

The immunochromatography according to claim 2,
wherein in the composite particle, an average particle diameter of the gold particles is smaller than an average particle diameter of the magnetic particles.

### Claim 14 (depends on 2)

The immunochromatography according to claim 2,
wherein an average particle diameter of the composite particles is 10 nm to 300 nm.

### Claim 15 (depends on 2)

The immunochromatography according to claim 2,
wherein the silver amplification step is a step of silver-amplifying the complex captured in the capturing step, using a reducing agent solution and a silver amplification solution.

### Claim 16 (depends on 15)

The immunochromatography according to claim 15,
wherein an angle between a developing direction of the reducing agent solution in the silver amplification step and a developing direction of the complex in the developing step is 0 degrees to 150 degrees.

### Claim 17 (depends on 15)

The immunochromatography according to claim 15,
wherein an angle between a developing direction of the silver amplification solution in the silver amplification step and a developing direction of the complex in the developing step is 45 degrees to 180 degrees.

### Claim 18 (depends on 2)

The immunochromatography according to claim 2,
wherein both optical detection and magnetic detection are possible.

### Claim 19 (depends on 3)

The immunochromatography according to claim 3,
wherein the number of carried gold particles of the composite particle is 1 or more and 300 or less.

### Claim 20 (depends on 3)

The immunochromatography according to claim 3,
wherein in the composite particle, an average particle diameter of the gold particles is smaller than an average particle diameter of the magnetic particles.
